top stories 

  •          No Top-Stories!        
Admin Reporter- POOJA1

Oct 27 2020


Cadila, one of India's two Covid vaccine makers, is going in for a huge capacity boost

Tuesday, 27 October 2020

Cadila Healthcare Ltd., one of two Indian drugmakers racing to develop an indigenous Covid-19 vaccine, is in talks with potential partners to ramp up production capacity if its candidate passes human clinical trials.

 

 

 

 

The Ahmedabad-based firm is looking to hire contract manufacturers for an additional 50 million to 70 million doses of its plasmid DNA vaccine, on top of the 100 million that will come from its own capacity, according to Managing Director Sharvil Patel. He declined to name the companies and the amount Cadila has invested in developing the vaccine.

instagram imagesfollow us @ instagram